Germline MBD4 deficiency causes a multi-tumor predisposition syndrome
暂无分享,去创建一个
M. Christie | D. Wedge | N. López-Bigas | R. Houlston | J. Weitz | C. Turnbull | J. Lubiński | F. Fostira | Jenny C. Taylor | M. Jenkins | L. Vreede | T. Graham | A. Sottoriva | S. Galavotti | Judith E Grolleman | T. van Wezel | R. Kuiper | D. Buchanan | M. Clendenning | Y. Goldberg | L. Thomas | C. Deltas | J. Cheadle | J. Sampson | Lynn Martin | G. Caravagna | I. Winship | I. Majewski | Claudia Arnedo-Pac | M. Sanders | Andreas J. Gruber | N. Hoogerbrugge | Hannah D. West | C. Flensburg | H. Curley | D. Power | V. Koelzer | B. Kinnersley | D. Chubb | Clara Ruiz Ponte | C. Palles | E. Arbe-Barnes | K. Mahmood | R. D. de Voer | W. Cross | R. S. van der Post | Ian Tomlinson | B. Noyvert | A. Dimovski | A. Bajel | C. Whalley | L. Chegwidden | D. Dymerska | D. Church | A. Frangou | D. Georgiou | E. Chew | E. Jansen | Nicola Lander | R. Truscott | J. Pagan | Kitty Sherwood | H. Thomas | David J. Adams | Simone A.M. van der Biezen | A. W. Roberts | M. Ligtenberg | Andrés Dacal Rivas | Andrew Green | I. Tomlinson | Judith E. Grolleman | H. Thomas | M. Jenkins | Richarda M. de Voer | Erik A. M. Jansen
[1] O. Mariani,et al. Germline MBD4 Mutations and Predisposition to Uveal Melanoma , 2020, Journal of the National Cancer Institute.
[2] A. V. D. van den Ouweland,et al. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines , 2019, Cancers.
[3] Y. Okazaki,et al. A germline MBD4 mutation was identified in a patient with colorectal oligopolyposis and early‑onset cancer: A case report. , 2019, Oncology reports.
[4] W. Foulkes,et al. Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype. , 2019, Cancer cell.
[5] S. Fröhling,et al. MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML. , 2018, Blood.
[6] Ville Mustonen,et al. The evolutionary landscape of colorectal tumorigenesis , 2018, Nature Ecology & Evolution.
[7] V. Servois,et al. Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors , 2018, Nature Communications.
[8] S. Nik-Zainal,et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer , 2017, Science.
[9] A. Shimamura,et al. Genetic predisposition to hematologic malignancies: management and surveillance. , 2017, Blood.
[10] Icgc,et al. Pan-cancer analysis of whole genomes , 2017, bioRxiv.
[11] L. Alexandrov,et al. Mutational signature analysis identifies MUTYH deficiency in colorectal cancers and adrenocortical carcinomas , 2017, The Journal of pathology.
[12] A. Giuliani,et al. A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer , 2017, EBioMedicine.
[13] J. Shendure,et al. A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer , 2015, Nature Genetics.
[14] A. Duval,et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD) , 2014, Journal of Medical Genetics.
[15] Peter Donnelly,et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2013, Nature Genetics.
[16] Peter Donnelly,et al. Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas , 2012, Nature Genetics.
[17] C. Cole,et al. COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.
[18] I. Tomlinson,et al. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer. , 2007, Gastroenterology.
[19] Alison L. Livingston,et al. Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors , 2002, Nature Genetics.
[20] N. Hayward,et al. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab , 2019, Immunogenetics.
[21] R. Pagon,et al. MUTYH Polyposis -- GeneReviews® , 2019 .
[22] L. Godley,et al. How I diagnose and manage individuals at risk for inherited myeloid malignancies. , 2016, Blood.